IRIS
CERULLO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 895
EU - Europa 425
AS - Asia 181
AF - Africa 21
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 865
IT - Italia 198
CN - Cina 119
NL - Olanda 61
FR - Francia 53
IN - India 44
CA - Canada 29
FI - Finlandia 27
IE - Irlanda 22
CI - Costa d'Avorio 19
DE - Germania 18
SE - Svezia 18
UA - Ucraina 15
VN - Vietnam 12
GB - Regno Unito 6
CL - Cile 2
IL - Israele 2
PK - Pakistan 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.525
Salva come PNG Salva come JPEG
Città #
Chandler 162
Millbury 81
Amsterdam 59
Ashburn 45
Napoli 42
Boston 39
Naples 39
Delhi 38
Princeton 38
Nanjing 33
Des Moines 32
Lawrence 30
Ottawa 27
Jacksonville 21
Wilmington 21
Nanchang 20
Seattle 17
Beijing 13
Dong Ket 12
Shanghai 12
Shenyang 11
Hebei 10
Jiaxing 10
Helsinki 9
Council Bluffs 7
Houston 7
Acerra 6
Kronberg 6
Pune 5
Lissone 4
Sesto Fiorentino 4
Changsha 3
Fairfield 3
Milan 3
Tianjin 3
Woodbridge 3
Ann Arbor 2
Boardman 2
Brindisi 2
Centro 2
Dublin 2
Ercolano 2
Rashidabad 2
Redwood City 2
Rome 2
Rotondi 2
San Jose 2
Toronto 2
Villarosa 2
Abbiategrasso 1
Arco 1
Bad Bellingen 1
Battipaglia 1
Bethesda 1
Bratislava 1
Capri 1
Casablanca 1
Casavatore 1
Catania 1
Cercola 1
Chengdu 1
Copenhagen 1
Falkenstein 1
Florence 1
Indiana 1
Jinan 1
Johannesburg 1
Krefeld 1
Lappeenranta 1
Leawood 1
Loreto 1
Los Angeles 1
New York 1
Newcastle Upon Tyne 1
Nola 1
Norwalk 1
Nova Siri 1
Panama City 1
Perito 1
Pescara 1
Potenza 1
Pozzuoli 1
Prague 1
Rehovot 1
Rochester 1
San Giorgio a Cremano 1
San Giovanni Rotondo 1
Stockholm 1
Taramani 1
Tel Aviv 1
Tempe 1
Torre Annunziata 1
Turin 1
Udine 1
Washington 1
Totale 947
Salva come PNG Salva come JPEG
Nome #
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 130
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy 59
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 57
Ischemic Neoangiogenesis Enhanced by {beta}2-Adrenergic Receptor Overexpression. A Novel Role for the Endothelial Adrenergic System. 51
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy. 51
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/ double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumour activity 50
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice 43
Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex 41
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 37
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice 33
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors 33
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors 33
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 32
AKT participates in endothelial dysfunction in hypertension. 31
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 30
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumor activity 28
PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile 27
Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. 26
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system. 26
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver 26
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach 26
Discovery of a new PCC-mediated stereoselective oxidative spiroketalization process. An access to a new type of poly-THF spiroketal compound displaying anticancer activity 25
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus 24
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus 24
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor 24
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 23
Generation of a helper-dependent adenoviral vector by homologous recombination 23
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients 23
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 22
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors 22
The evolution of adenoviral vectors through genetic and chemical surface modifications 21
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses 21
Design and application of oncolytic viruses for cancer immunotherapy 21
Solid phase synthesis of new dinuclear platinum complexes having a modified nucleoside as ligand. 20
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 20
Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus 19
Artificially cloaked viral nanovaccine for cancer immunotherapy 18
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy 17
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification 17
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 16
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 15
Toll-like Receptor 9 Triggers an Innate Immune Response to Helper-dependent Adenoviral Vectors. 14
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 14
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 13
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging 13
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction 13
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma 13
Short-Term Correction of Arginase Deficiency in a Neonatal Murine Model with a Helper-Dependent Adenoviral Vector. 12
Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus 12
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans 12
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site 12
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 12
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform 12
Oncolytic adenoviruses for cancer therapy 11
Thiol-ene surface modifications for microchip electrophoresis based interaction assays 11
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to Helper-dependent adenovirus. 11
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment 11
Uncovering the tumor antigen landscape: What to know about the discovery process 11
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy 11
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance 10
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy 10
GMCSF-armed vaccinia virus induces an antitumor immune response 9
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus 9
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 9
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus 8
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo 8
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy 8
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients 7
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin 7
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids 7
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: Assessment of safety and immunologic responses in patients 6
Pathogens: Our Allies against Cancer? 6
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses 6
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery 5
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) 4
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 4
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 3
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 2
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 2
Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions 2
Totale 1.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 2 3 9
2019/2020153 81 2 5 5 10 2 4 0 0 5 23 16
2020/2021132 5 2 36 3 6 12 5 20 13 5 9 16
2021/2022348 6 0 0 7 1 11 3 12 48 11 78 171
2022/2023486 71 47 11 20 50 44 1 54 71 70 25 22
2023/2024312 31 76 52 19 15 36 19 58 3 3 0 0
Totale 1.635